Keep informed about the latest topics in global health.
#VaccinesWork
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
African Vaccine Manufacturing Accelerator (AVMA)
COVID-19
The Global Vaccine Impact Conference explained
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
FEATURED STORY
Everything you need to know about Gavi's incoming CEO, Dr Sania Nishtar
VACCINE PROFILES
Read series
KEY PUBLICATION
The 2023 Mid-Term Review Report
PROGRESS REPORT
7 October 2011
GAVI congratulates Nobel Peace Prize winner
15 September 2011
GAVI welcomes new data on falling child mortality
17 August 2011
Panacea Biotec “Easyfive” pentavalent vaccine loses WHO prequalification
8 August 2011
Update on audit of GAVI cash-based support to Zambia 2006-2009
28 July 2011
GAVI and the Union for International Cancer Control to mark World Hepatitis Day
Gemeinsame Stellungnahme der GAVI Alliance und der Internationalen Vereinigung gegen Krebs (UICC) zum Welt-Hepatitis-Tag
17 July 2011
Milestone in preventing child deaths from diarrhoea in Africa
6 July 2011
GAVI welcomes Australian Review of Aid Effectiveness
1 July 2011
GAVI welcomes J.P. Morgan’s £1.5 million donation to new matching fund for immunisation
9 June 2011
Developing nations take increasing responsibility for immunisation
Entwicklungsländer übernehmen mehr Verantwortung für Impfprogramme
19 May 2011
GAVI and Government of Mali resolve misuse of funds case